OTCMKTS:SEOVF

Sernova Biotherapeutics Earnings Date & Estimates

Sernova Biotherapeutics logo
$0.07 0.00 (-2.40%)
As of 11/20/2026 02:39 PM Eastern

Sernova Biotherapeutics is estimated to report earnings on Thursday, December 17, 2026.

What Analysts Expect from Sernova Biotherapeutics

Sernova Biotherapeutics is expected to post earnings of -$0.0072 per share. In the same quarter a year earlier Sernova Biotherapeutics reported -$0.01 per share. Sernova Biotherapeutics last reported on September 10, 2026, posting -$0.01 per share and missing the -$0.0050 consensus estimate. Sernova Biotherapeutics has beaten the consensus EPS estimate in 1 of its last 4 quarters.

Consensus Estimates

Consensus EPS
-$0.0072
Prior-Year EPS
-$0.01

Recent Track Record

Last Reported
Q3 2026
Last Quarter EPS
-$0.01 (Missed by -$0.0050)
EPS Beat Rate
1 of last 4 quarters

Sernova Biotherapeutics Earnings FAQ

Sernova Biotherapeutics (OTCMKTS:SEOVF) is estimated to report earnings on Thursday, December 17, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Sernova Biotherapeutics to post earnings of -$0.0072 per share for the quarter.

Sernova Biotherapeutics Earnings Headlines

Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
Sernova Biotherapeutics Inc (SVA)
See More Sernova Biotherapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sernova Biotherapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sernova Biotherapeutics and other key companies, straight to your email.

About Sernova Biotherapeutics

Sernova Biotherapeutics (OTCMKTS:SEOVF) is a Canadian biotechnology company developing regenerative medicine technologies that use therapeutic cells to treat chronic diseases. Its primary platform, the Cell Pouch System, is an implantable device designed to support blood-vessel growth around transplanted cells.

The company has focused on combining the Cell Pouch with insulin-producing islet cells as a potential treatment for type 1 diabetes. Its research has also included cell-based approaches for other conditions, such as thyroid disease and hemophilia. These programs are investigational, and the company’s technologies are not established treatments.

View Sernova Biotherapeutics Profile